Additional file 1: Table S1. of Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer

IC50 values and SEM for fifty-five colorectal cancer cell lines treated with TAK-960 as assessed by CyQuant proliferation assay. (TIFF 689 kb